Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $495.84 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $155.83 | 2 | $0 (2022) |
| Allergan, Inc. | $129.61 | 8 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.86 | 5 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $49.95 | 2 | $0 (2017) |
| PFIZER INC. | $40.72 | 3 | $0 (2018) |
| GlaxoSmithKline, LLC. | $16.13 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $13.98 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $13.76 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $155.83 | 2 | ABIOMED ($155.83) |
| 2020 | $22.13 | 1 | Allergan, Inc. ($22.13) |
| 2019 | $64.92 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($28.70) |
| 2018 | $13.46 | 1 | PFIZER INC. ($13.46) |
| 2017 | $239.50 | 15 | Allergan Inc. ($85.24) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/30/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $73.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/05/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $82.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/22/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: DIABETES | ||||||
| 05/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: DIABETES | ||||||
| 03/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/28/2017 | SANOFI-AVENTIS U.S. LLC | LANTUS (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: DIABETES | ||||||
| 11/07/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/30/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/01/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/17/2017 | SANOFI-AVENTIS U.S. LLC | LANTUS (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: DIABETES | ||||||
| 04/30/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/26/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: RESPIRATORY | ||||||
| 04/24/2017 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/04/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/24/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug), JARDIANCE, STIOLTO | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/31/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, STIOLTO | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/26/2017 | GlaxoSmithKline, LLC. | ANORO (Drug), BREO, INCRUSE | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 304 | 597 | $111,276 | $43,703 |
| 2022 | 6 | 273 | 503 | $109,432 | $41,665 |
| 2021 | 7 | 363 | 596 | $124,048 | $48,526 |
| 2020 | 7 | 378 | 570 | $124,212 | $48,577 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 127 | 396 | $50,688 | $24,445 | 48.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 134 | 138 | $39,054 | $12,288 | 31.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $15,312 | $3,814 | 24.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 34 | $6,222 | $3,157 | 50.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 105 | 323 | $56,202 | $25,543 | 45.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 96 | 100 | $26,900 | $8,037 | 29.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $12,550 | $3,812 | 30.4% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $8,388 | $2,264 | 27.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 14 | 22 | $2,662 | $1,229 | 46.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 15 | 15 | $2,730 | $780.37 | 28.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 125 | 319 | $55,506 | $25,938 | 46.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 122 | 123 | $33,087 | $10,103 | 30.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 44 | 76 | $9,196 | $3,986 | 43.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 24 | 24 | $12,048 | $3,671 | 30.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 15 | 16 | $7,456 | $2,310 | 31.0% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 18 | 23 | $4,025 | $1,721 | 42.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 15 | 15 | $2,730 | $797.72 | 29.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 123 | 276 | $47,644 | $22,595 | 47.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 107 | 109 | $29,089 | $9,143 | 31.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 40 | 40 | $20,022 | $6,123 | 30.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 56 | 92 | $11,120 | $5,254 | 47.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 24 | 24 | $11,170 | $3,522 | 31.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 12 | 13 | $2,275 | $1,080 | 47.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 16 | 16 | $2,892 | $859.00 | 29.7% |
About Dr. Sujit Muthukuru, M.D
Dr. Sujit Muthukuru, M.D is a Internal Medicine healthcare provider based in Kettering, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2016. The National Provider Identifier (NPI) number assigned to this provider is 1679925689.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sujit Muthukuru, M.D has received a total of $495.84 in payments from pharmaceutical and medical device companies, with $155.83 received in 2022. These payments were reported across 23 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($495.84).
As a Medicare-enrolled provider, Muthukuru has provided services to 1,318 Medicare beneficiaries, totaling 2,266 services with total Medicare billing of $182,472. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Hospitalist
- Location Kettering, OH
- Active Since 07/01/2016
- Last Updated 05/05/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679925689
Products in Payments
- Impella (Device) $155.83
- TEFLARO (Drug) $71.43
- LANTUS (Drug) $49.95
- AVYCAZ (Drug) $39.81
- JARDIANCE (Drug) $28.70
- ELIQUIS (Drug) $28.62
- DALVANCE (Drug) $18.37
- STIOLTO (Drug) $17.65
- ANORO (Drug) $16.13
- SPIRIVA (Drug) $14.91
- PRADAXA (Drug) $14.60
- XARELTO (Drug) $13.98
- ENTRESTO (Drug) $13.76
- CHANTIX (Drug) $12.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Kettering
Saleem Ahmad, M.d, M.D
Internal Medicine — Payments: $39,651
Malek Safa, M.d, M.D
Internal Medicine — Payments: $16,090
Dr. Rami Alashram
Internal Medicine — Payments: $6,176
Dr. Carlos Ventura, M.d, M.D
Internal Medicine — Payments: $6,043
Dr. Archana Kodali, M.d, M.D
Internal Medicine — Payments: $5,326
Mrs. Kelly Miller, Md, Phd, MD, PHD
Internal Medicine — Payments: $3,766